# Novabay Pharmaceuticals

- Location (FDA's records): Emeryville, CA
- FDA decisions: 5 (2007–2015): 5 510(k) clearances
- Names in FDA's records: Novabay Pharmaceuticals (3); Novabay Pharmaceuticals, Inc. (2)
- Product codes: FRO (3), KMF (1), LRX (1)
- Predicates its devices cite: 10 (3 its own); citations of its devices by later devices: 8 (3 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Oculus Innovative Sciences: 4 (https://510kreport.com/company/oculus-innovative-sciences)
- Puricore, Inc.: 1 (https://510kreport.com/company/puricore)
- Anacapa Technologies, Inc.: 1 (https://510kreport.com/company/anacapa-technologies)

## Firms that cite its devices most
- Nawa Heilmittel GmbH: 2 (https://510kreport.com/company/nawa-heilmittel)
- Aquilabs Us, LLC: 1 (https://510kreport.com/company/aquilabs-us)
- Puricore, Inc.: 1 (https://510kreport.com/company/puricore)
- Apr Applied Pharma Research SA: 1 (https://510kreport.com/company/apr-applied-pharma-research)

## Its most-cited devices
- K113820: Neutrophase Antimicrobial Wound Cleanser (2012), cited by 5
- K071056: Neutrophase Wound Cleanser (2007), cited by 1
- K131542: Neutrophase (R) Skin and Wound Cleanser Otc (2013), cited by 1
- K081009: Neutrophase (2008), cited by 1

## Recent decisions
- K143351: iCase Contact Lens Case (Apr 29, 2015)
- K131542: Neutrophase (R) Skin and Wound Cleanser Otc (Jul 24, 2013)
- K113820: Neutrophase Antimicrobial Wound Cleanser (Aug 8, 2012)
- K081009: Neutrophase (May 20, 2008)
- K071056: Neutrophase Wound Cleanser (Sep 28, 2007)

Source page: https://510kreport.com/company/novabay-pharmaceuticals